America Great Health

America Great Health

AAGH
America Great HealthUS flagOther OTC
0.00
USD
- -
- -
2.12MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
159
- -
19,981
20,049
20,182
20,236
20,236
20,236
20,439
21,090
21,093
21,123
21,144
21,152
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-1,620.25
- -
-1,522.01
- -
- -
- -
- -
-843.09
-124.47
-4,523.83
-241.13
-265.62
-97.75
-100.1
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-1
-1
-1
- -
- -
- -
- -
-5
-1
-1
-1
1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,641.77
- -
-1,486.13
- -
- -
- -
- -
-948.41
-137.5
-4,650.02
-372.68
-414.22
-183.57
164.42
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3
-3
-3
-4
-2
LT Debt
- -
- -
- -
1
- -
- -
- -
- -
1
1
2
2
2
2
Total Equity
- -
- -
-1
-1
- -
- -
- -
- -
- -
-4
-4
-5
-6
-5
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-13.45
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'25
Sep'26
Dec'26
ST Debt
1
1
1
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21,153
21,153
21,153
Market Capitalization
6
8
2

Working Capital

FRC

in mil. unless spec.
Jun'25
Sep'26
Dec'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
4
3
Payables & Accruals
3
3
2
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
100.78%
177.07%
12.07%
Free Cash Flow
153.07%
205.38%
-45.93%
Net Income, GAAP
201.9%
412.35%
-41.08%
Sales/Revenue/Turnover
- -
720.09%
32.94%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Mike Qingkun Wang
Full Time Employees
5
Sector
Healthcare
Industry
Biotechnology
Address
1609 West Valley Boulevard Alhambra CA United States of America 91803
IPO Date
Sep 25, 2012
Website
aaghus.com
Business
America Great Health, Inc. (AAGH) operates as a biotechnology company focused on the research, development, and commercialization of protein and peptide small molecular drugs; AI cloud computing-based diagnostic and medical devices including proton therapy systems, cardio quantum spectrum diagnostic systems, and smart stethoscopes; cell therapy and regenerative medicine solutions such as stem cell therapies and Purecell group offerings; and nutritional dietary supplements with personal care products. The company, founded in 1997 as Crown Marketing and renamed America Great Health in March 2017 following a change of control, maintains its headquarters at 1609 W. Valley Blvd., Unit 338A, Alhambra, California, and conducts operations primarily in the United States. Recent developments include new product launches driving sales growth as reported in its first quarter 2025 Form 10-Q filing, alongside an earlier agreement to acquire a 51% stake in Health & Beauty Group, Inc. for $0.76 million, and ongoing efforts to raise capital for expansion into innovative healthcare technologies.